Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability denotes differences within the same individual over time. These variabilities stem from unique biological factors such as genetics, age, body weight, and organ function, influencing how a drug is absorbed, distributed, metabolized, and excreted–collectively known as pharmacokinetic variability.
On the other hand, pharmacodynamic variability involves patients responding differently to the same drug concentration due to variations in the number of receptors, endogenous substances, or other physiological differences. The significance of individualized dosing regimens is especially pronounced in determining dose strengths and therapeutic index (TI). TI is the ratio between a drug's effective dose and its toxic dose, and a narrow TI means a drug must be dosed with precision to avoid toxicity while maintaining efficacy. For Generally Recognized as Safe (GRAS) and over-the-counter (OTC) drugs, which are widely regarded as safe for public use without a prescription, individualization might be less stringent compared to drugs with a narrow TI. Drugs having a narrow therapeutic index (NTI), like warfarin or digoxin, require meticulous individualization. Small dosage changes can lead to significant fluctuations in plasma drug concentrations, potentially causing therapeutic failure or adverse reactions. In conclusion, individualizing dosage regimens is a critical component of personalized medicine, offering a tailored approach to drug therapy. It considers the variability among and within patients, aiming to optimize therapeutic outcomes by balancing efficacy and safety.
Pharmacokinetic variability refers to differences in how the body processes drugs, while pharmacodynamic variability describes differences in how individuals respond to a drug, even at the same concentration.
Drug responses vary due to factors such as genetics, disease, and age, causing intersubject variability, where different patients experience distinct pharmacological responses to the same drug dose.
In contrast, intrasubject variability occurs when the same individual exhibits differences in plasma drug levels upon receiving the same medication on different occasions.
Individualized dosing tailors medication to each person's unique response to optimize treatment outcomes and minimize risks.
Key factors in individualized regimens include dose strengths, the degree of intersubject variability, and the therapeutic index, among others.
For instance, drugs with a narrow therapeutic index require precise dosing to prevent fluctuations in plasma drug concentrations, which could lead to adverse effects or therapeutic failure.
However, GRAS and over-the-counter drugs typically require less stringent individualization.
繁體中文
